Enamel repair does not end when the appointment is over
Enamel compromise is often managed in the surgery, but its recovery rarely stays there. Children with molar-incisor hypomineralisation, adolescents leaving fixed orthodontic treatment, and patients with early demineralisation all depend on what happens after the dental chair is empty. The practical challenge is not simply to detect damaged enamel, but to keep vulnerable tooth surfaces supplied with the mineral support they need while everyday oral conditions continue to strip and stress them.
MIH remains one of the most frustrating problems in paediatric dentistry because the defect is structural rather than cosmetic. Enamel may appear chalky or demarcated, then break down after eruption, leaving hypersensitivity, caries risk and a surface that can be difficult to bond to during orthodontic treatment. A large epidemiological study across five regions in northern England found MIH in 15.9% of 12-year-old children, a reminder that this is not a niche diagnosis in UK practice. Once the tooth surface is compromised, the clinical question shifts from isolated repair to continuous protection.
A single intervention cannot restore a mineral imbalance that keeps unfolding in the mouth.
Biomimetic mineral support and the Biosmalto approach
Curasept Biosmalto is presented as a bio-inspired system built to support enamel and dentin through remineralisation-oriented formulations. The central concept is biomimicry: matching the oral environment with mineral components that behave in ways the tooth can use. In practical terms, that means trying to replenish the hard tissue matrix with materials that can interact with enamel rather than merely coat it.
A key element in the range is F-ACP Complex, used in Curasept Biosmalto Mousse. The formulation contains amorphous calcium phosphate nanoparticles enriched with carbonate and fluoride and coated with citrate. Amorphous calcium phosphate is designed to act as a reservoir of calcium and phosphate ions, the raw materials of remineralisation, while fluoride can strengthen the newly formed mineral and improve resistance to future acid attack. Citrate coating helps stabilise the complex and supports ion release in the oral environment. For a tooth surface exposed to repeated demineralising episodes, that ion availability is the biologic logic behind the product design.
The toothpaste line adds bioactive hydroxyapatite-based formulations. Hydroxyapatite is structurally similar to the mineral component of enamel, so its presence is intended to support mineral replenishment and reinforce the surface. The appeal of this approach is straightforward: if enamel is losing mineral, then a daily product built around mineral delivery offers a plausible way to complement professional care between appointments.
Orthodontic white spot lesions and the case for structured home care
Post-orthodontic white spot lesions are one of the clearest examples of why daily support matters. Brackets create niches for plaque retention, and even diligent patients can develop visible demineralisation around the appliance. Once treatment ends, those lesions may persist as a cosmetic and biological reminder of the period of fixed appliance wear. For teenagers and young adults, that residual damage can carry real weight because it is often noticed immediately after bracket removal, when expectations are highest.
The product range is offered in toothpaste, mouthwash and mousse formats, which allows the mineral-support strategy to be integrated into different phases of care. Toothpaste and mouthwash fit naturally into daily hygiene routines. The mousse adds another level of flexibility because it can be applied with a brush or, where clinically appropriate, a suitable tray or orthodontic retainer. That matters in post-orthodontic care, where a retainer can become a vehicle for prolonged contact between the formulation and the tooth surface. Continuous exposure is the point: demineralised enamel does not recover from a brief encounter.
Trial data in adolescents with post-orthodontic lesions
The clinical potential of the F-ACP Complex was examined in a randomised controlled trial at Bambino Gesù Children’s Hospital in Rome. The study enrolled 106 adolescents aged 12 to 20 who had completed fixed orthodontic treatment and had white spot lesions. Participants in the study arm used Curasept Biosmalto toothpaste containing bioactive hydroxyapatite formulations together with F-ACP-containing mousse applied through Essix retainers for six months. The control arm used conventional fluoride toothpaste.
Ninety-one participants completed the study. At six months, the F-ACP group showed a significantly greater reduction in ICDAS scores than the control group, with p = 0.001. ICDAS is a clinically useful scoring system because it tracks the visible severity of carious and demineralised changes rather than forcing the clinician to rely only on broad impressions. In this setting, a lower score indicates improvement in the appearance and status of the lesion. The six-month image follow-up described in the article showed no visible evidence of white spot lesions after five seconds of air drying in a participant from the F-ACP arm, a striking practical endpoint for families and clinicians watching for cosmetic recovery.
The result is not merely about one product outperforming another in a trial setting. It reflects a broader principle in preventive dentistry: enamel repair works best when the dentist’s intervention is extended into a disciplined home protocol that keeps mineral delivery going long enough for the surface to stabilise.
What this means for MIH, demineralisation and retention protocols
For patients with MIH, early enamel lesions, or residual damage after orthodontics, the clinical message is consistent. Enamel care is cumulative. A repair strategy that ends at the chairside risks leaving vulnerable teeth exposed to the same daily acid challenges, plaque retention and mechanical stress that caused the damage in the first place. When the mineral balance of the tooth is already compromised, continuity becomes the therapeutic principle.
The appeal of a biomimetic system lies in its ability to align with that principle. A mousse delivered through a retainer, a toothpaste built around hydroxyapatite, and a routine that can be followed at home create a bridge between professional intervention and long-term maintenance. In a paediatric or adolescent population, that bridge may be especially important because the teeth remain in active development and the adherence burden sits with patients and families rather than the clinician.
The evidence presented here remains centered on post-orthodontic white spot lesions, so its strongest clinical support is in that setting. MIH, early demineralisation and broader enamel reinforcement are adjacent uses, but they are not interchangeable outcomes. The remaining question is how far this biomimetic model can be extended across different enamel defects, different risk profiles and longer follow-up periods without losing its effect.
For now, the trial data point to one concrete conclusion: remineralisation strategies work best when they are not treated as a one-off prescription but as an ongoing part of oral disease management.